Search Results - Steve Woolfenden
- Showing 1 - 1 results of 1
-
1
Model‐based dose selection to inform translational clinical oncology development of WNT974, a first‐in‐class Porcupine inhibitor by Yan Ji, Pai‐Hsi Huang, Steve Woolfenden, Andrea Myers
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book